| BMI ≥ 35.4 | GA at diagnosis ≤ 30 weeks | Past history | Family history | Albumin dipstick 4+ |
Sensitivity | 66.7% | 84.8% | 48.5% | 30.3% | 24.2% |
Specificity | 67.2% | 41.8% | 73.1% | 88.1% | 97.0% |
DA | 67.0% | 56.0% | 65.0% | 69.0% | 73.0% |
YI | 33.8% | 26.6% | 21.6% | 18.4% | 21.3% |
PPV | 50.0% | 41.8% | 47.1% | 55.6% | 80.0% |
NPV | 80.4% | 84.8% | 74.2% | 72.0% | 72.2% |
LR+ | 2.03 | 1.46 | 1.80 | 2.54 | 8.12 |
LR− | 0.50 | 0.36 | 0.70 | 0.79 | 0.78 |
DOR | 4.09 | 4.02 | 2.56 | 3.21 | 10.40 |
| Oligohydramnios | IUGR | Admission SBP ≥ 138.0 | Admission DBP ≥ 87.0 | Platelets ≥ 163.0 |
Sensitivity | 30.3% | 36.4% | 39.4% | 39.4% | 54.5% |
Specificity | 88.1% | 83.6% | 85.1% | 85.1% | 80.6% |
DA | 69.0% | 68.0% | 70.0% | 70.0% | 72.0% |
YI | 18.4% | 19.9% | 24.5% | 24.5% | 35.1% |
PPV | 55.6% | 52.2% | 56.5% | 56.5% | 58.1% |
NPV | 72.0% | 72.7% | 74.0% | 74.0% | 78.3% |
LR+ | 2.54 | 2.21 | 2.64 | 2.64 | 2.81 |
LR− | 0.79 | 0.76 | 0.71 | 0.71 | 0.56 |
DOR | 3.21 | 2.91 | 3.71 | 3.71 | 4.98 |